Molecular mechanisms of MLC1 and GLIALCAM mutations in megalencephalic leukoencephalopathy with subcortical cysts

Tania López-Hernández, Sònia Sirisi, Xavier Capdevila-Nortes, Marisol Montolio, Victor Fernández-Dueñas, Gert C. Scheper, Marjo S. van der Knaap, Pilar Casquero, Francisco Ciruela, Isidre Ferrer, Virginia Nunes, Raúl Estévez

Research output: Contribution to journalArticleAcademicpeer-review

74 Citations (Scopus)

Abstract

Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare leukodystrophy caused by mutations in MLC1 or GLIALCAM. The GLIALCAM gene product functions as an MLC1 beta-subunit. We aim to further clarify the molecular mechanisms of MLC caused by mutations in MLC1 or GLIALCAM. For this purpose, we analyzed a human post-mortem brain obtained from an MLC patient, who was homozygous for a missense mutation (S69L) in MLC1. We showed that this mutation affects the stability of MLC1 in vitro and reduces MLC1 protein levels in the brain to almost undetectable. However, the amount of GlialCAM and its localization were nearly unaffected, indicating that MLC1 is not necessary for GlialCAM expression or targeting. These findings were supported by experiments in primary astrocytes and in heterologous cells. In addition, we demonstrated that MLC1 and GlialCAM form homo- and hetero-complexes and that MLC-causing mutations in GLIALCAM mainly reduce the formation of GlialCAM homo-complexes, leading to a defect in the trafficking of GlialCAM alone to cell junctions. GLIALCAM mutations also affect the trafficking of its associated molecule MLC1, explaining why GLIALCAM and MLC1 mutations lead to the same disease: MLC
Original languageEnglish
Pages (from-to)3266-3277
JournalHuman Molecular Genetics
Volume20
Issue number16
DOIs
Publication statusPublished - 2011

Cite this